Learn more

UNIV TOKYO

Overview
  • Total Patents
    5,887
  • GoodIP Patent Rank
    596
  • Filing trend
    ⇩ 1.0%
About

UNIV TOKYO has a total of 5,887 patent applications. It decreased the IP activity by 1.0%. Its first patent ever was published in 1959. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ISIS INNOVATION, UNIV CALIFORNIA and UNIV CORNELL.

Patent filings per year

Chart showing UNIV TOKYOs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Shimoyama Isao 131
#2 Kataoka Kazunori 122
#3 Nakauchi Hiromitsu 115
#4 Urano Yasuteru 112
#5 Matsumoto Kiyoshi 109
#6 Nagano Tetsuo 102
#7 Suga Hiroaki 99
#8 Yamada Atsuo 98
#9 Kawai Tomoyuki 89
#10 Ohkoshi Shin-Ichi 88

Latest patents

Publication Filing date Title
WO2021075566A1 Quantum gate and quantum computer
WO2021075511A1 Two-dimensional wireless power feeding sheet and two-dimensional wireless power feeding system
WO2021070920A1 Cyclic peptide
WO2021070906A1 Fluorescent probe for detecting puromycin-sensitive aminopeptidase or bleomycin hydrolase
WO2021066178A1 Method for detecting atopic dermatitis
WO2021070739A1 Analysis device, analysis method, and program
WO2021066136A1 Therapeutic agent for muscular dystrophy
WO2021065936A1 Iron-based oxide magnetic powder and method for manufacturing same
WO2021060470A1 METHOD FOR GROWING SiC CRYSTALS
WO2021060425A1 Pharmaceutical composition for treatment of systemic scleroderma
WO2021060467A1 Method for producing megakaryocyte progenitor cell and megakaryocytic cell, and megakaryocyte progenitor cell and megakaryocytic cell obtained thereby
WO2021065686A1 Nucleic acid that inhibits expression of mex3b gene, mex3b gene expression inhibiting agent, method for inhibiting mex3b gene expression, and prophylactic or therapeutic agent for disease caused by mex3b gene expression
WO2021060303A1 Microparticles
WO2021054473A1 Agent for ameliorating and/or preventing sickle cell disease
WO2021060076A1 Information processing device, information processing system, information processing method, and program
WO2021049652A1 Acoustic output device and acoustic output method
WO2021049617A1 Serum-free medium not containing albumin and suited for culturing human hematopoietic stem cells, and albumin-free culturing method
WO2021070553A1 Wireless power supply system, power transmission device, and power reception device
WO2021070556A1 Wireless power receiving system, moving body, and wheel
WO2021070555A1 Wireless power receiving system, mobile body, and wheel